Your browser doesn't support javascript.
loading
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
D'Angelica, Michael I; Ellis, Ryan J; Liu, Jason B; Brajcich, Brian C; Gönen, Mithat; Thompson, Vanessa M; Cohen, Mark E; Seo, Susan K; Zabor, Emily C; Babicky, Michele L; Bentrem, David J; Behrman, Stephen W; Bertens, Kimberly A; Celinski, Scott A; Chan, Carlos H F; Dillhoff, Mary; Dixon, Matthew E B; Fernandez-Del Castillo, Carlos; Gholami, Sepideh; House, Michael G; Karanicolas, Paul J; Lavu, Harish; Maithel, Shishir K; McAuliffe, John C; Ott, Mark J; Reames, Bradley N; Sanford, Dominic E; Sarpel, Umut; Scaife, Courtney L; Serrano, Pablo E; Smith, Travis; Snyder, Rebecca A; Talamonti, Mark S; Weber, Sharon M; Yopp, Adam C; Pitt, Henry A; Ko, Clifford Y.
Afiliação
  • D'Angelica MI; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ellis RJ; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Liu JB; American College of Surgeons, Chicago, Illinois.
  • Brajcich BC; American College of Surgeons, Chicago, Illinois.
  • Gönen M; Brigham and Women's Hospital, Boston, Massachusetts.
  • Thompson VM; American College of Surgeons, Chicago, Illinois.
  • Cohen ME; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Seo SK; American College of Surgeons, Chicago, Illinois.
  • Zabor EC; American College of Surgeons, Chicago, Illinois.
  • Babicky ML; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Bentrem DJ; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Behrman SW; The Oregon Clinic/Providence Portland Medical Center, Portland.
  • Bertens KA; Northwestern University, Chicago, Illinois.
  • Celinski SA; Baptist Memorial Medical Education, Memphis, Tennessee.
  • Chan CHF; University of Ottawa, Ottawa, Ontario, Canada (K.A.B.).
  • Dillhoff M; Baylor University Medical Center, Dallas, Texas.
  • Dixon MEB; University of Iowa Hospitals and Clinics, Iowa City.
  • Fernandez-Del Castillo C; Ohio State University Cancer Center, Columbus.
  • Gholami S; Rush University Medical Center, Chicago, Illinois.
  • House MG; Massachusetts General Hospital, Boston.
  • Karanicolas PJ; University of California Davis, Sacramento.
  • Lavu H; Indiana University Health, Indianapolis.
  • Maithel SK; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • McAuliffe JC; Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Ott MJ; Emory University Hospital, Atlanta, Georgia.
  • Reames BN; Montefiore Medical Center, New York, New York.
  • Sanford DE; Intermountain Healthcare, Murray, Utah.
  • Sarpel U; University of Nebraska Medical Center, Omaha.
  • Scaife CL; Washington University School of Medicine, St Louis, Missouri.
  • Serrano PE; Mount Sinai Medical Center, New York, New York.
  • Smith T; Huntsman Cancer Institute, Salt Lake City, Utah.
  • Snyder RA; McMaster University, Hamilton, Ontario, Canada.
  • Talamonti MS; Gunderson Health System, La Crosse, Wisconsin.
  • Weber SM; The University of Texas MD Anderson Cancer Center, Houston.
  • Yopp AC; NorthShore University Health, Evanston, Illinois.
  • Pitt HA; University of Wisconsin, Madison.
  • Ko CY; University of Texas Southwestern Medical Center, Dallas.
JAMA ; 329(18): 1579-1588, 2023 05 09.
Article em En | MEDLINE | ID: mdl-37078771
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cefoxitina / Sepse Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Humans / Male Idioma: En Revista: JAMA Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cefoxitina / Sepse Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Humans / Male Idioma: En Revista: JAMA Ano de publicação: 2023 Tipo de documento: Article